# Organon & Co. (OGN) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Organon & Co.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/OGN/mda/fy2025/): filed 2026-02-24; accession 0001628280-26-011125 (https://www.sec.gov/Archives/edgar/data/1821825/000162828026011125/ogn-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/OGN/mda/fy2024/): filed 2025-02-28; accession 0001821825-25-000006 (https://www.sec.gov/Archives/edgar/data/1821825/000182182525000006/ogn-20241231.htm)
- [FY 2023 MD&A](/company/OGN/mda/fy2023/): filed 2024-02-26; accession 0001628280-24-006733 (https://www.sec.gov/Archives/edgar/data/1821825/000162828024006733/ogn-20231231.htm)
- [FY 2022 MD&A](/company/OGN/mda/fy2022/): filed 2023-02-27; accession 0001821825-23-000003 (https://www.sec.gov/Archives/edgar/data/1821825/000182182523000003/ogn-20221231.htm)
- [FY 2021 MD&A](/company/OGN/mda/fy2021/): filed 2022-03-21; accession 0001821825-22-000002 (https://www.sec.gov/Archives/edgar/data/1821825/000182182522000002/ogn-20211231.htm)

Back to /company/OGN/